We are live on ! Find out more
Lazard Asset Management

Lazard Asset Management Portfolio holdings

AUM $60.8B
1-Year Est. Return 22.47%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$68.4B
AUM Growth
-$6.42B
Cap. Flow
-$9.95B
Cap. Flow %
-14.55%
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$433M
2
MRK icon
Merck
MRK
+$286M
3
J icon
Jacobs Solutions
J
+$265M
4
EFX icon
Equifax
EFX
+$253M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$240M

Sector Composition

Rank Sector Weight
1 Technology 26.04%
2 Financials 14.64%
3 Healthcare 12%
4 Industrials 10.54%
5 Consumer Discretionary 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
1451
TG Therapeutics
TGTX
$7.54B
$191K ﹤0.01%
6,376
-2,977
-32% -$85.4K
BRKR icon
1452
Bruker
BRKR
$8.07B
$190K ﹤0.01%
3,252
-23,124
-88% -$1.37M
FIVN icon
1453
FIVE9
FIVN
$2.56B
$190K ﹤0.01%
4,693
+4,655
+12,250% +$168K
OFG icon
1454
OFG Bancorp
OFG
$2.21B
$189K ﹤0.01%
4,488
-14,301
-76% -$616K
OKE icon
1455
Oneok
OKE
$55.4B
$188K ﹤0.01%
1,882
-2,716
-59% -$278K
GMED icon
1456
Globus Medical
GMED
$11.1B
$187K ﹤0.01%
2,271
-369
-14% -$29.1K
NOG icon
1457
Northern Oil and Gas
NOG
$2.35B
$186K ﹤0.01%
5,023
-348
-6% -$13.6K
PCB icon
1458
PCB Bancorp
PCB
$391M
$186K ﹤0.01%
+9,239
New +$184K
TDG icon
1459
TransDigm Group
TDG
$67.6B
$185K ﹤0.01%
147
-99
-40% -$130K
ENLC
1460
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$185K ﹤0.01%
13,161
-1,033
-7% -$15.4K
GRAB icon
1461
Grab
GRAB
$14.9B
$182K ﹤0.01%
38,629
SEB icon
1462
Seaboard Corp
SEB
$4.11B
$182K ﹤0.01%
75
+54
+257% +$148K
ACA icon
1463
Arcosa
ACA
$7.12B
$180K ﹤0.01%
1,871
-127
-6% -$12.8K
HBCP icon
1464
Home Bancorp
HBCP
$567M
$180K ﹤0.01%
+3,916
New +$185K
IWN icon
1465
iShares Russell 2000 Value ETF
IWN
$14.6B
$180K ﹤0.01%
1,100
CTO
1466
CTO Realty Growth
CTO
$815M
$179K ﹤0.01%
+9,118
New +$179K
ORI icon
1467
Old Republic International
ORI
$10.4B
$179K ﹤0.01%
5,000
+1,088
+28% +$39.7K
DHI icon
1468
D.R. Horton
DHI
$41.5B
$178K ﹤0.01%
1,281
-28,230
-96% -$4.72M
ADPT icon
1469
Adaptive Biotechnologies
ADPT
$3.9B
$177K ﹤0.01%
+29,807
New +$164K
SYF icon
1470
Synchrony
SYF
$25.5B
$177K ﹤0.01%
2,738
+1,183
+76% +$72.4K
USFD icon
1471
US Foods
USFD
$23.8B
$175K ﹤0.01%
2,608
-175
-6% -$11.5K
VSXY
1472
Victoria's Secret
VSXY
$7.7B
$173K ﹤0.01%
4,213
-283
-6% -$10K
AMRC icon
1473
Ameresco
AMRC
$1.38B
$172K ﹤0.01%
7,371
+4,362
+145% +$126K
DD icon
1474
DuPont de Nemours
DD
$19.5B
$172K ﹤0.01%
1,807
-205
-10% -$21.3K
FSBW icon
1475
FS Bancorp
FSBW
$318M
$172K ﹤0.01%
4,190
+1,495
+55% +$66.7K

Similar funds

Lazard Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.

  • Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
  • Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
  • Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
  • Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
  • Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
  • Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
  • Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.